Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial

作者：Pedro Cahn, Richard Kaplan, Paul E. Sax, Kathleen Squires, Jean‐Michel Molina, Anchalee Avihingsanon, Winai Ratanasuwan, Evelin Rojas, Mohammed Rassool, Mark Bloch, Linos Vandekerckhove, Peter Ruane, Yazdan Yazdanpanah, Christine Katlama, Xia Xu, Anthony Rodgers, Lilly East, Larissa Wenning, Sandy Rawlins, Brenda Homony, Peter Sklar, Bach‐Yen Nguyen, Randi Y. Leavitt, Hedy Teppler, PE Cahn, Isabel Cassetti, Marcelo H. Losso, MT Bloch, N Roth, James McMahon, Robert J. Moore, D.P. Smith, Nathan Clumeck, Linos Vanderkerckhove, B Vandercam, Michel Moutschen, Jean-Guy Baril, Brian Conway, Fiona Smaill, GHR Smith, Anita Rachlis, Sharon Walmsley, Carlos Enrique Tene Pérez, Marcelo Wolff, M. Lasso, CE Chahin, JD Velez, Otto Sussmann, Jacques Reynes, Christine Katlama, Yazdan Yazdanpanah, Samuel Ferret, J Durant, C Duvivier, Isabelle Poizot‐Martin, F. Ajana, JK Rockstroh, G Faetkanheuer, S Esser, Hans Jaeger, Olaf Degen, Markus Bickel, J. R. Bogner, Keikawus Arastéh, H Hartl, Albrecht Stoehr, EM Rojas, Eduardo Arathoon, LD Gonzalez, Christian R. Mejía, Eduardo Shahar, Dianna Turner, Idan Levy, Zev Sthoeger, Hila Elinav, Andrea Gori, Antonella d’Arminio Monforte, Giampaolo Perri, Adriano Lazzarin, G Rizzardini, Andrea Antinori, Benedetto Maurizio Celesia, F Maggiolo, TS Chow, CKC Lee, Iskandar Azwa, Mohammad Mustafa, Martin Oyanguren, RA Castillo, L. Hercilla, Carmenchu Echiverri, Fernando Maltêz, JG Saraiva da Cunha, Isabel Neves, Eugénio Teófilo, Rosário Serrão, Ф. И. Нагимова, И. М. Хаертынова, Elena Orlova‐Morozova, Evgeny Voronin, V. I. Sotnikov, AA Yakovlev, Н. Ф. Захарова, O Tsybakova, ME Botes, Lerato Mohapi, Richard Kaplan, MS Rassool, José Ramón Arribas, JM Gatell, Eugènia Negredo, Enrique Ortega, Jesús Troya, Juan Berenguer, Koldo Aguirrebengoa, Antonio Antela, Alexandra Calmy, Matthias Cavassini, Alan Rauch, Marcel Stoeckle, Wang‐Huei Sheng, Honghuang Lin, Hsing-Chen Tsai, Dhitiwat Changpradub, Anchalee Avihingsanon, Sasisopin Kiertiburanakul, Winai Ratanasuwan, M Nelson, Amanda Clarke, Andrew Ustianowski, Alan Winston, MA Johnson, David M. Asmuth, Jamil Cade, JE Gallant, P. Ruane, PN Kumar, A. Luque, Lori Panther, K. Tashima, Denise Ward, DS Berger, CA Dietz, Carl J. Fichtenbaum, Samir K. Gupta, Mullane Km, RM Novak, DE Sweet, GE Crofoot, DP Hagins, ST Lewis, C McDonald, E DeJesus, Louis Sloan, DJ Prelutsky, JC Rondon, S Henn, A. Scarsella, JO Morales, Ramirez, L Santiago, C D Zorrilla, MS Saag, CB Hsiao · 发表于：The Lancet HIV · 年份：2017 · DOI：10.1016/s2352-3018(17)30128-5 · 被引用次数：35 · 研究领域：HIV/AIDS drug development and treatment、HIV Research and Treatment、HIV/AIDS Research and Interventions